In vivo Exposure Effects of 99mTc-methoxyisobutylisonitrile on the FDXR and XPA Genes Expression in Human Peripheral Blood Lymphocytes

Document Type : Original Article

Authors

1 Medical Physics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

2 Department of Medical Physics, Faculty of Medicine, Azadi Square, Pardis Campus, Mashhad-Iran.

3 Medical Physics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

4 Immunology Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

5 Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

Abstract

Objective(s): In recent years, the application of radiopharmaceuticals in nuclear medicine has increased substantially. Following the diagnostic procedures performed in nuclear medicine departments, such as myocardial perfusion imaging, patients generally receive considerable doses of radiation. Normally, radiation-induced DNA damages are expected following exposure to a low-dose ionizing radiation. In order to detect molecular changes, high-sensitivity techniques must be utilized. The aim of this study was to assess the effect of a low-dose (below 10 mSv) gamma ray on gene expression using quantitative real-time polymerase chain reaction (qRT-PCR). Methods: Blood samples were obtained from 20 volunteer patients who underwent myocardial perfusion imaging. They were given various doses of Technetium99-m methoxyisobutylisonitrile (99mTc-MIBI). After that, peripheral blood mononuclear cells (PBMNs) were derived, and then total RNA was extracted and reverse-transcribed to cDNA. Finally, the expression levels of xeroderma pigmentosum complementation group-A (XPA) and ferredoxin reductase (FDXR) genes were determinded through qRT-PCR technique using SYBR Green. Results: XPA and FDXR expression levels were obtained following a very low-dose ionizing radiation. A significant up-regulation of both genes was observed, and the gene expression level of each individual patient was different. If differences in the administered activity and radiosensitivity are taken into account, the observed differences could be justified. Furthermore, gender and age did not play a significant role in the expression levels of the genes under study. Conclusion: The up-regulation of FDXR after irradiation revealed the high-sensitivity level of this gene; therefore, it could be used as an appropriate biomarker for biological dosimetry. On the other hand, the up-regulation of XPA is an indication of DNA repair following radiation exposure. According to linear no-threshold model (LNT) and the results obtained from this study, a very low dose of ionizing radiation could bring about adverse biological effects at molecular level in the irradiated person.

Keywords

Main Subjects


  1.  

    1. Manning G, Kabacik S, Finnon P, Bouffler S, Badie C. High and low dose responses of transcriptional biomarkers in ex vivo x-irradiated human blood. Int J Radiat Biol. 2013;89(7):512-22.
    2. Morgan WF, Bair WJ. Issues in low dose radiation biology: the controversy continues. A perspective. Radiat Res. 2013;179(5):501-10.
    3. Mettler FA Jr, Huda W, Yoshizumi TT, Mahesh M. Effective doses in radiology and diagnostic nuclear medicine: a catalog. Radiology. 2008;248(1):254-63.
    4. Einstein AJ, Moser KW, Thompson RC, Cerqueira MD, Henzlova MJ. Radiation dose to patients from cardiac diagnostic imaging. Circulation. 2007;116(11):1290-305.
    5. Baggish AL, Boucher CA. Radiopharmaceutical agents for myocardial perfusion imaging. Circulation. 2008;118(16):1668-74.
    6. Taibi N, Aka P, Kirsch-Volders M, Bourgeois P, Frühling J, Szpireer C. Radiobiological effect of 99mTechnetium-MIBI in human peripheral blood lymphocytes: ex vivo study using micronucleus/ FISH assay. Cancer Letters. 2006;233(1):68-78.
    7. Nosel I, Vaurijoux A, Barquinero JF, Gruel G. Characterization of gene expression profiles at low and very low doses of ionizing radiation. DNA Repair. 2013;12(7):508-17.
    8. Li L, Story M, Legerski RJ. Cellular responses to ionizing radiation damage. Int J Radiat Oncol Biol Phys. 2001;49(4):1157-62.
    9. Dainiak N, Schreyer SK, Albanese J. The search for mRNA biomarkers: global quantification of transcriptional and translational responses to ionising radiation. Br J Radiol. 2005;1:114-22.
    10. Azimian H, Bahreyni-Toossi MT, Rezaei AR, Rafatpanah H, Hamzehloei T, Fardid R. Up-regulation of Bcl-2 expression in cultured human lymphocytes after exposure to low doses of gamma radiation. J Med Phys. 2015;40(1):38-44.
    11. Hesse B, Tägil K, Cuocolo A, Anagnostopoulos C, Bardies M, Bax J, et al. EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology. Eur J Nucl Med Mol Imaging. 2005;32(7):855-97.
    12. Eberlein U, Bröer JH, Vandevoorde C, Santos P, Bardiès M, Bacher K, et al. Biokinetics and dosimetry of commonly used radiopharmaceuticals in diagnostic nuclear medicine–a review. Eur J Nucl Med Mol Imaging. 2011;38(12):2269-81.
    13. Corbett JR, Akinboboye OO, Bacharach SL, Borer JS, Botvinick EH, DePuey EG, et al. Equilibrium radionuclide angiocardiography. J Nucl Cardiol. 2006;13(6):e56-79.
    14. Saha GB. Physics and radiobiology of nuclear medicine. New York: Springer Science and Business Media; 2006.
    15. Fenech M, Bonassi S. The effect of age, gender, diet and lifestyle on DNA damage measured using micronucleus frequency in human peripheral blood lymphocytes. Mutagenesis. 2011;26(1):43-9.
    16. Joksic G, Petrovic S, Ilic Z. Age-related changes in radiation-induced micronuclei among healthy adults. Braz J Med Biol Res. 2004;37(8):1111-7.
    17. Badie C, Kabacik S, Balagurunathan Y, Bernard N, Brengues M, Faggioni G, et al. Laboratory intercomparison of gene expression assays. Radiat Res. 2013;180(2):138-48.
    18. Knops K, Boldt S, Wolkenhauer O, Kriehuber R. Gene expression in low-and high-dose-irradiated human peripheral blood lymphocytes: possible applications for biodosimetry. Radiat Res. 2012;178(4):304-12.
    19. Wood RD, Mitchell M, Sgouros J, Lindahl T. Human DNA repair genes. Science. 2001;291(5507):1284-9.
    20. Boldt S, Knops K, Kriehuber R, Wolkenhauer O. A frequency-based gene selection method to identify robust biomarkers for radiation dose prediction. Int J Radiat Biol. 2012;88(3):267-76.
    21. Harms K, Nozell S, Chen X. The common and distinct target genes of the p53 family transcription factors. Cell Mol Life Sci. 2004;61(7-8):822-42.
    22. Fachin AL, Mello SS, Sandrin-Garcia P, Junta CM, Ghilardi-Netto T, Donadi EA, et al. Gene expression profiles in radiation workers occupationally exposed to ionizing radiation. J Radiat Res. 2009;50(1):61-71.
    23. Paul S, Amundson SA. Development of gene expression signatures for practical radiation biodosimetry. Int J Radiat Oncol Biol Phys. 2008;71(4):1236-44.
    24. Kabacik S, Mackay A, Tamber N, Manning G, Finnon P, Paillier F, et al. Gene expression following ionising radiation: identification of biomarkers for dose estimation and prediction of individual response. Int J Radiat Biol. 2011;87(2):115-29.
    25. Knops K, Boldt S, Wolkenhauer O, Kriehuber R. Gene expression in low-and high-dose-irradiated human peripheral blood lymphocytes: possible applications for biodosimetry. Radiat Res. 2012;178(4):304-12.
    26. Azimian H, Bahreyni-Toossi MT, Rezaei AR, Rafatpanah H, Hamzehloei T, Fardid R. Up-regulation of Bcl-2 expression in cultured human lymphocytes after exposure to low doses of gamma radiation. J Med Phys. 2015;40(1):38-44.
    27. Vodicka P, Stetina R, Polakova V, Tulupova E, Naccarati A, Vodickova L, et al. Association of DNA repair polymorphisms with DNA repair functional outcomes in healthy human subjects. Carcinogenesis. 2006;28(3):657-64.
    28. Hosseinimehr S, Ahmadi A, Beiki D, Mahmoudzadeh A, Babaei M, Habibi E. The radiotracer 99mTc- MIBI is not genotoxic for human peripheral blood lymphocytes at diagnostic radioactive dose. Gene Mol Res. 2009;8(3):923-8.
    29. Kelsey KT, Donohoe KJ, Memisoglu A, Baxter B, Caggana M, Liber HL. In vivo exposure of human lymphocytes to technetium-99 m in nuclear medicine patients does not induce detectable genetic effects. Mutat Res Letters. 1991;264(4):213-8.
    30. Monson RR, Cleaver JE, Abrams HL. BEIR VII: health risks from exposure to low levels of ionizing radiation (report in brief). BEIR VII Report; 2005.
    31. Ghandhi SA, Ponnaiya B, Panigrahi SK, Hopkins KM, Cui Q, Hei TK, et al. RAD9 deficiency enhances radiation induced bystander DNA damage and transcriptomal. Radiat Oncol. 2014;9(1):206.